CDKN2A and breast cancer: In normal tissues adjacent to breast cancer, p16INK4a was expressed only in nuclei of occasional cells (Figure 2), while p16INK4a showed aberrant staining of tumor cells in 29.35% (27/92) of breast cancers, and this positive staining was generally present in both the nuclei and cytoplasm (Figure 2).